FDA DEVICE FACTS
Fast Absorbing PGLA
Riverpoint Medical, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Fast absorbing PGLA suture is indicated for use in superficial soft tissue approximation of the skin and mucosa, where only short-term wound support (7-10 days) is required, but not for use in ligation, ophthalmic, cardiovascular or neurological procedures. Fast absorbing PGLA suture is provided sterile as a single use device. Substantial Equivalence and Comparison of Technical Characteristics The Fast absorbing PGLA sutures within this submission have substantially equivalent technological characteristics as the predicate device listed. As with the predicate device, Fast absorbing PGLA sutures are braided, coated, synthetic absorbable surgical sutures. The Fast absorbing PGLA sutures absorbable sutures are provided sterile for one-time use only and meet USP requirements unless stated otherwise within labeling. The only difference from the predicate device is the updated labeling related to the addition of a contraindication where the subject device is not for use in ligation, ophthalmic, cardiovascular, or neurological procedures
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。